Frangible Connector Vial Group for Space and Contamination Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for storing and transporting pharmaceutical vials are inefficient in terms of space and cost, particularly for vaccines that require specific temperature ranges, leading to increased storage and transport costs and potential for cross-contamination.
Innovation Solution
Affixed groups of pharmaceutical vials with frangible connectors, where each vial is shaped and positioned to minimize volume and connected with reversible mating surfaces and frangible connectors, allowing for efficient packing and easy tracking of doses, while minimizing cross-contamination.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Volume of moving object
If pharmaceutical vials are stored and transported in traditional separate packaging, then each vial can be individually accessed, but storage and transport costs increase and space efficiency decreases
Solution Approach 1:
The packaging system is segmented into multiple individual vial compartments within a single group structure, allowing each vial to be separately accessed while maintaining efficient group packaging. The frangible connectors enable individual vials to be separated from the group when needed, providing both space efficiency and individual access capability.
Solution Approach 2:
Multiple individual vials are combined into a single affixed group structure with shared packaging elements, reducing overall packaging material and improving space efficiency during storage and transport. The vials remain physically connected through frangible connectors, maintaining integrity while optimizing space utilization.
2Productivity
If pharmaceutical vials are arranged to minimize group volume, then packing efficiency improves, but access and separation of individual vials becomes more difficult
Solution Approach 1:
The frangible connectors provide a dynamic connection system that transitions from a connected state during storage to a separable state during access. The connectors are designed to be intact during transport for space efficiency but can be easily broken when individual vial access is required, adapting to different operational needs.
Solution Approach 2:
The mechanical strength parameter of the connection between vials is changed by using frangible connectors that are strong enough to maintain group integrity during storage but weak enough to be easily broken for separation. This parameter optimization allows the system to achieve both compact packing and easy access.
3Reliability
If traditional packaging methods are used, then individual vial protection is maintained, but storage and transport costs increase
Solution Approach 1:
Multiple vials share common packaging structures and protective elements within the affixed group, reducing the total amount of packaging material needed compared to individual separate packaging. This merging approach maintains protection for each vial while reducing overall material usage and associated costs.
Solution Approach 2:
The group packaging structure serves multiple functions simultaneously: it provides individual vial protection, enables efficient space utilization during storage and transport, and allows for easy identification and access of specific vials. This multi-functionality reduces the need for additional separate packaging components.
Data Source
AI summary
In some embodiments, an affixed group of pharmaceutical vials with frangible connectors includes: a plurality of pharmaceutical vials arranged as a group of pharmaceutical vials, each of the plurality of pharmaceutical vials shaped and positioned to minimize a total volume of the group of pharmaceutical vials, each of the pharmaceutical vials including at least one external side with a surface configured to reversibly mate with a corresponding external side and a surface of an adjacent pharmaceutical vial; and a plurality of frangible connectors, wherein at least one frangible connector is affixed to the surface of at least two of the plurality of pharmaceutical vials within the group of pharmaceutical vials, and at least one frangible connector is affixed to each of the plurality of pharmaceutical vials.


